Jump to main content
Topic: Drug Pricing
-
Bottom-Up Pricing Estimate for P-quad
Read More
-
Modeling P-quad
Read More
-
Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students
Read More
-
Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead
Read More
-
Dissecting PhRMA’s Opposition to H.R. 3 Lower Drug Costs Now Act of 2019
Read More
-
US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light
Read More
-
Remdesivir Less Expensive for “Government Programs”? Not So Fast.
Read More
-
Blueprints for Indication-Specific Pricing
Read More
-
Pharmaceutical Products and Their Value
Read More
-
Understanding the Rewards of Successful Drug Development: Thinking Inside the Box
Read More